Wade Sexton, MD
Dr. Sexton attended Furman University in Greenville, South Carolina as a scholar-athlete and graduated with a Bachelor of Science Degree in Biology. While at Furman, he was a member of Furman’s National Championship football team. He attended Emory University’s School of Medicine on an Air Force sponsored Health Professions Scholarship and then completed his general surgery and urology residency training at the Wake Forest University Baptist Medical Center. Following the completion of his residency, Dr. Sexton entered active duty military service with the United States Air Force and while on active duty, was selected to perform a Fellowship in Urologic Oncology at the University of Texas MD Anderson Cancer Center. From 2001-2004, he served as Director of Urologic Oncology with the 59th Medical Wing at Wilford Hall USAF Medical Center in San Antonio, Texas. Thereafter, he joined the Moffitt Cancer Center in Tampa, Florida, where he is now a Senior Member in the Department of Genitourinary Oncology and a Professor in the Department of Oncologic Sciences with the University of South Florida. Since 2008, he has served as Director of the Society of Urologic Oncology accredited Fellowship at the Moffitt Cancer Center. Dr. Sexton has held several leadership positions at Moffitt including an extended service on the Medical Executive Committee culminating as President of the Medical Staff from 2014-2016, and he was recently appointed as the Director for the Moffitt Cancer Center Robotics Program. He is a 2014 graduate of the inaugural Moffitt Cancer Center Leadership Academy. He has served in different capacities with the Florida Urologic Society (FUS) including president of the FUS from 2015-2016. He is a long-term member of the National Comprehensive Cancer Network (NCCN) guidelines panel for bladder and penile cancers, a faculty member for the American Urological Association (AUA) Annual Board Review Course (testicular cancer), and holds membership on both the Fellowship Committee and the Board of Directors for the Society of Urologic Oncology (SUO). He is primary investigator and collaborator on numerous clinical trials and grant funded translational studies, has authored over 100 peer reivewed manuscripts and book chapters, and maintains an extremely busy clinical practice focused towards bladder, kidney and testicular malignancies. Dr. Sexton has a special interest in minimally invasive kidney-sparing procedures, bladder reconstruction and nerve preservation surgery, as well as advanced urologic laparoscopic and robotic procedures. He was awarded a Meritorious Service Medal while on active duty with the United States Air Force. In 2013, it was a tremendous honor for him to be recognized as an MD Anderson Cancer Center Distinguished Alumnus. He has been recognized as a Top Doctor in Tampa Bay and repeatedly as one of America’s Top Physicians, Top Surgeons and Top Doctors for Cancer.
No financial relationships have been disclosed.